The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Summary Background Time-dependent changes in glycemic control might represent a strong predictor for coronary artery disease. Since a higher benefit from outpatient appointments has been discussed for female gender, the aim of the study was to assess gender differences in HbA1c levels and metabolic parameters at baseline as well as over 3 years of follow-up. Methods We analyzed the data of 54 female...
In der Behandlung des Typ-2-Diabetes gewinnt der Endocannabinoidblocker Rimonabant an Bedeutung, dessen Wirkprofil die Reduktion des HbA1c, eine Gewichtsabnahme und eine Reduktion weiterer kardiometabolischer Risikofaktoren beinhaltet. Die SERENADE-Studie („study evaluating rimonabant efficacy in drug naive diabetic patients“) untersuchte die antidiabetische Wirkung (primärer Endpunkt: HbA1c) von...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.